VETRANO, STEFANIA

VETRANO, STEFANIA  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 78 (tempo di esecuzione: 0.018 secondi).
Titolo Data di pubblicazione Autore(i) File
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 1-gen-2019 Tacconi, C; Ungaro, F; Correale, C; Arena, V; Massimino, L; Detmar, M; Spinelli, A; Carvello, M; Mazzone, M; Oliveira, Ai; Rubbino, F; Garlatti, V; Spanò, S; Lugli, E; Colombo, Fs; Malesci, A; Peyrin-Biroulet, L; Vetrano, S; Danese, S; D'Alessio, S
Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus 1-gen-2005 Picarelli, A; Sabbatella, L; Di Tola, M; Vetrano, S; Casale, C; Anania, Mc; Porowska, B; Vergari, M; Schiaffini, R; Gargiulo, P
Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? 1-gen-2016 Genua, M; Becker, C; Vetrano, S
Antiendomysial antibody detection in fecal supernatants: In vivo proof that small bowel mucosa is the site of antiendomysial antibody production 1-gen-2002 Picarelli, A; Sabbatella, L; Di Tola, M; Di Cello, T; Vetrano, S; Anania, Mc
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 1-gen-2010 Correale, C; Martinoli, C; Vetrano, S; Mazzini, E; Caprioli, F; Spinelli, A; Arena, V; Fiorino, G; Passini, N; Panina, P; Repici, A; Malesci, A; Rescigno, M; Danese, S
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 1-gen-2013 Correale, C.; Genua, M.; Vetrano, S.; Mazzini, E.; Martinoli, C.; Spinelli, A.; Arena, V.; Peyrin Biroulet, L.; Caprioli, F.; Passini, N.; Panina Bordignon, P.; Repici, A.; Malesci, A.; Rutella, S.; Rescigno, M.; Danese, S.
Cathelicidins: A Novel Therapy for the Treatment of Intestinal Fibrosis 1-gen-2015 Vetrano, S; Genua, M
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study 1-gen-2017 Westera, L; van Viegen, T; Jeyarajah, J; Azad, A; Bilsborough, J; van den Brink, Gr; Cremer, J; Danese, S; D'Haens, G; Eckmann, L; Faubion, W; Filice, M; Korf, H; Mcgovern, D; Panes, J; Salas, A; Sandborn, Wj; Silverberg, Ms; Smith, Mi; Vermeire, S; Vetrano, S; Shackelton, Lm; Stitt, L; Jairath, V; Levesque, Bg; Spencer, Dm; Feagan, Bg; Casteele, Nv
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 1-gen-2008 Vetrano, S.; Correale, C.; Borroni, E. M.; Pagano, N.; Bruno, Savino; Locati, M.; Malesci, A.; Repici, A.; Danese, S.
Colitis, microbiota and colon cancer: an infernal triangle 1-gen-2013 Vetrano, S; Danese, S
Colitis-associated cancer: the dark side of inflammatory bowel disease 1-gen-2011 Danese, S.; Malesci, A.; Vetrano, S.
Contrast-enhancement at magnetic resonance enterography does not differentiate between fibrosis and inflammation in Crohn's disease: a prospective cohort study 1-gen-2015 Fiorino, G.; Spinelli, A.; Bonifacio, C.; Spaggiari, P.; Grizzi, F.; Gandelli, A.; Morenghi, E.; Allocca, M.; Sacchi, M.; Roncalli, M.; Balzarini, L.; Montorsi, M; Malesci, A.; Vetrano, S.; Danese, S.
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 1-gen-2007 Danese, S; Scaldaferri, F; Vetrano, S; Stefanelli, T; Graziani, C; Repici, A; Ricci, R; Straface, G; Sgambato, A; Malesci, A; Fiocchi, C; Rutella, S
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 1-gen-2007 Scaldaferri, F; Sans, M; Vetrano, S; Graziani, C; De Cristofaro, R; Gerlitz, B; Repici, A; Arena, V; Malesci, A; Panes, J; Grinnell, Bw; Danese, S
Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease 1-gen-2007 Vetrano, S; Zampaletta, U; Anania, Mc; Di Tola, M; Sabbatella, L; Passarelli, F; Maffia, C; Sanjust, Mg; Lettieri, F; De Pita, O; Picarelli, A
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 1-gen-2011 Fiorino, G; Naccarato, P; Szabo, H; Vetrano, S; Sociale, O; Repici, A; Biroulet, Lp; Malesci, A; Danese, S
Effect of Tumor Necrosis Factor-alpha Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease 1-gen-2013 Biancheri, P; Di Sabatino, A; Rovedatti, L; Giuffrida, P; Calarota, Sa; Vetrano, S; Vidali, F; Pasini, A; Danese, S; Corazza, Gr; Macdonald, Tt
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 1-gen-2012 Fiorino, G.; Peyrin Biroulet, L.; Naccarato, P.; Szabò, H.; Sociale, O. R.; Vetrano, S.; Fries, W.; Montanelli, A.; Repici, A.; Malesci, A.; Danese, S.
Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease 1-gen-2010 Laverny, G; Penna, G; Vetrano, S; Correale, C; Nebuloni, M; Danese, S; Adorini, L
Endothelial Tpl2 regulates vascular barrier function via JNK-mediated degradation of claudin-5 promoting neuroinflammation or tumor metastasis 1-gen-2021 Nanou, Aikaterini; Bourbouli, Mara; Vetrano, Stefania; Schaeper, Ute; Ley, Steven; Kollias, George